Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FXM46
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $113,328
Award facts
- Contract value 100% obligated
- $113,328.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $113,328.08 to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pens on September 23, 2025, with final delivery required by September 24, 2025. This competitively awarded, firm fixed-price contract requires performance at the vendor's Conshohocken, Pennsylvania location. DUPIXENT (dupilumab) is a monoclonal antibody used to treat various allergic and inflammatory conditions, including moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis, making this procurement consistent with the Defense Health Agency's pharmaceutical supply needs for military personnel and beneficiaries.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies supporting military healthcare systems worldwide. The contract represents the company's ongoing role as a primary pharmaceutical supplier to the Defense Health Agency and other federal healthcare programs through the DLA's medical supply chain network.
Quick answers
Who was awarded contract SPE2DB25FXM46?
SPE2DB25FXM46 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FXM46 worth?
The government has obligated $113,328 on SPE2DB25FXM46.
Is contract SPE2DB25FXM46 an order under another contract?
Yes. SPE2DB25FXM46 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXM46 competed?
The extent of competition for SPE2DB25FXM46 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award